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Summary
Coimplantation of small fragments ofhuman fetal thymus and fetal liver into immunodeficient
SCID mice resulted in the formation of a unique structure (Thy/Liv) . Thereafter, the SCID-hu
mice showed reproducible and long-term reconstitution of human hematopoietic activity. For
periods lasting 5-11 mo after transplantation, active T lymphopoiesis was observed inside the
grafts and cells that were negative for T cell markers were found to have colony-forming units
for granulocyte/macrophage (CFU-GM) and erythroid burst-forming unit (BFU-E) activity in
the methylcellulose colony assay. In addition, structures similar to normal human bone marrow
were observed inside the Thy/Liv grafts, consisting of blast cells, mature and immature forms
of myelomonocytic cells, and megakaryocytes . These data indicate long-term maintenance, in
vivo, of human progenitor cells for the T lymphoid, myelomonocytic, erythroid, and mega-
karyocytic lineages . The role of the implanted fetal liver fragments was analyzed using HLA-
mismatched Thy/Liv implants. The HLA type of the liver donor was found on T cells and
macrophages in the graft . In addition, cells grown in the methylcellulose colony assay and cells
in a bone marrow-like structure, the "thymic isle," expressed the HLA type of the liver donor.
Thus, the Thy/Liv implants provided a microenvironment in which to followhuman hematopoietic
progenitor cells for multiple lineages. The formation of the Thy/Liv structures also results in
a continuous source ofhuman T cells in the peripheral circulation of the SCID-hu mouse . Though
present for 5-11 mo, these cells did not engage in a xenograft (graft-versus-host) reaction . This
animal model, the first in which multilineage human hematopoietic activity is maintained for
long periods of time, should be useful for the analysis of human hematopoiesis in vivo.
n vivo experiments with the laboratory mouse have con-
tributed much to our understanding of the mammalian
hematopoietic system . Adoptive transfer ofcongeneic hema-
topoietic cells into lethally irradiated hosts has shown that
some populations of cells have the capacity to differentiate
along multiple lineages . Mature progeny are thereafter as-
sayed by sampling cells in the peripheral blood and/or colo-
nies formed in the spleen (1) . In this fashion, considerable
information has been gathered about murine hematopoietic
progenitor cells (2-5) . The in vivo effects of hematopoietic
growth factors have also been demonstrated in experiments
with laboratory animals (6-9) .
Methods acceptable for use in the mouse cannot be easily
transferred to man . As a result, analogous aspects ofhuman
hematopoiesis are much less well defined. Several attempts
have been made instead to transfer critical elements of the
human hematopoietic system into a mouse (10-12) . After in-
travenous inoculation ofhuman bone marrow cells into im-
munodeficient bg/nu/xid mice, human colony-forming units
for macrophage and granulocyte/macrophage (CFU-M and
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CFU-GM),' and erythroid-burst forming units (BFU-E)
were later recovered from the mouse bone marrow (12) . In
another experiment, progenitor cells from human fetal liver
were administered intravenously to immunodeficient C.B-17
scid/scid (SCID) mice (13) that had been previously engrafted
with human fetal thymus. Later, the maturation of human
T cells and myelomonocytic cells could be observed (14) . Al-
though each of these experimental systems did show evidence
ofhuman hematopoiesis, neither provided conditions neces-
sary for long-term reconstitution with human cells of mul-
tiple lineages. Likely, human hematopoietic stem cells were
either not provided, not maintained, and/or unable to differen-
tiate as they normally would .
Given the complex regulatory mechanisms that surround
hematopoiesis, it seems likely that human stem cells would
best survive within a physiologic microenvironment that is
1 Abbreviations used in this paper. BFU-E, erythroid burst-forming unit;
CFU-c, colony-forming units in culture ; CFU-GM, CFU for granulo-
cyte/macrophage ; gw, gestational weeks ; TN, triple negative .
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vironment was not provided . We report now that when in-
tact fragments of human fetal liver and thymus are coim-
planted into the SCID mouse, structural elements similar to
human bone marrow are observed to form andto remain func-
tional for periods of time as long as 15 mo. These elements
are associated with multilineagehumanhematopoietic differen-
tiation. This animal model should provide a powerful tool
for the analysis of the physiology and pathophysiology of
human hematopoiesis .
Materials and Methods
Construction ofSCID-huMice.
￿
HomozygousC.B-17 scid/scid mice
(SCID) were bred, treated with antibiotics as described (14), and
used when 6-8 wk old . Methoxyflurane anesthesia was applied
during all operative procedures . Before implantation, cells from
human fetalthymus (14-23 gestational weeks [gw]) or liver (18-23
gw) were typed forMHC class I alloantigens on aFACS . Thymus
and liver were cut with a sharp blade into small pieces (N1 x 1
x 1 mm) . One to two of these fragments were implanted under
the kidney capsule ofSCID mice with a 18-gauge trocar. Atten-
tion was paid to confirm that these fragments stayedclose together
under the capsule. Mice receivingthymus fragment alone weredesig-
natedThy/- ; those implanted with a combination of thymus and
liver fragmentswere designated Thy/Liv. Based on the HLA allo-
type analysis, Thy/Liv implants that were allogeneic with respect
to one another were prepared so that cell movement could later
be traced.
Analysis ofThymic Grafts.
￿
Themice were killed by cervical dis-
location and the graftunder the kidney capsule wasremovedunder
sterile conditions and placed in HBSS (without phenol red; Gibco
Laboratories, Grand Island, NY) supplemented with 2% FCS and
10 mM Hepes (HBSS-FCS) . Approximately one-thirdofthe tissue
was frozen for immunohistology; the remainder was teased into
a single cell suspension for analysis by immunofluorescence (for
phenotype) and by methylcellulose culture (for the presence of
colony-forming units) .
Antibodies.
￿
Mouse mAbs against human T cell markers and
humanMHCclass I antigens were directly conjugated with FITC
or PE. These includedOKT3 (CD3), OKT4 (CD4), OKT8 (CD8),
W6/32 (monomorphic class I determinant), MA2 .1 (HLA-A2,
B17), BB7.2 (HLAA2), BB7.1 (HLAB7, Bw42), MB40.2(HLA
B7, B40), and GAPA3 (HLA-A3) . FITC- or PE-HLel (CD45) and
LeuMl (CD15) were purchased from Becton Dickinson Immu-
nocytometry Systems, San Jose, CA . The mouse mAb MEM-43,
which stains all hematopoietic cells of human origin, was kindly
provided by Dr.V Hofej§i, Institute ofMolecular Genetics, Czecho-
slovak AcademyofSciences, Praha, Czechoslovakia (15) . The mouse
mAbLy5.1 was obtained from Dr. G. Spangrude, Rocky Moun-
tain Laboratories, Hamilton, MT, it reacts against most of the he-
matopoietic cells in the SCID mouse . Both MEM-43 and Ly5.1
were biotinylated . All antibodies and reagents were titrated and
used at saturating concentrations .
Immunohistochemistry .
￿
Phenotypic characterization ofcells in bi-
opsy sections from the grafts was carried outusing standard tech-
niques . In brief, 6-P.m frozen sections were prepared, fixed with
acetone, and then sequentially incubated with a first-stage mAb
followed by biotinylated horse anti-mouse IgG (Vector Laborato-
ries, Inc., Burlingame, CA) . Alkaline phosphatase (ALP)-conjugated
avidin (Caltag Laboratories, South San Francisco, CA) was added
and visualized using the substrate naphthol-AS phosphate (Sigma
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Chemical Co., St . Louis, MO)with Fast BlueBB salt (Sigma Chem-
icalCo.) . Endogenous phosphatase activity was blocked by adding
levamisole (0.25 mM) in the reaction .
Colony-farming Units in Culture(CFU-c) Assay.
￿
Selection for cells
that were triple negative (TN) for CD3, CD4, and CD8 was
performed by immunomagnetic bead separation (5, 16) . The cell
suspension wasincubated first with a cocktail ofantibodies, FITC-
OKT3, -OKT4, and -OKT8, and then with magnetic beads cou-
pled to sheep anti-FITC antibodies (Advanced Magnetics, Cam-
bridge, MA) . CD3', 4', and 8' cells were removed by magnetic
depletion . The degree of enrichment of the TN cells was deter-
mined afterwards by FRCS . TheTN fraction as well as unsepa-
rated populations were assayed for the presence of clonal hemato-
poietic progenitor cells in semisolid medium, using previously
described methods (17) . Briefly, TN cells or wholethymocytes were
plated in 35-mm petri dishes at a concentration of 5-10 x 10^/ml
or 1 x 106/ml, respectively, in 1-ml cultures consisting of 1%
methylcellulose (1,500 centipoises, Sigma Chemical Co .) in IMDM
(Gibco Laboratories) containing 20% FCS, 0.05 mM 2-ME, 200
mm L-glutamine, 0.8% lept-albumin (Armour Pharmaceutical,
Tarrytown, NY), 0.08% NaHC03, and human recombinant
erythropoietin (Amgen Biologicals, Thousand Oaks, CA) at the
concentration of 1 U/ml, and 10% Mo-conditioned media (18) .
The methylcellulose cultures were incubated at 37°C in ahumidified
atmosphere of 5% C0 2 in air and were counted after 10-14 d to
determine the total number ofcolonies per dish. CFU-cwere charac-
terized as having greater than 30 cells and consistedmainly ofgran-
ulocytes and macrophages (CFU-GM) or multiple clusters of
erythroid cells (BFU-E), although other lineages could be observed
in some of the colonies . The number of the colonies was normal-
ized per 105 pure TN cells based on the results of FACS analysis
of the cells after magnetic bead separation .
Immunofuorescence Analysis.
￿
Immunofluorescence analysis with
a single laser FACScan (Becton Dickinson Immunocytometry
Systems) was performed with the cell suspensions from the grafts
and cells recoveredfrom CFU-c . Thymocytes from the grafts were
analyzed for their CD4/CD8 profiles with PE-OKT4 and FITC-
OKT8 . Cellsfrom CFU-GM andBFU-E colonies in the methyl-
cellulose cultures were picked with a narrowed glass pipette and
pooled . They were then stainedwith biotinylated MEM-43 or Ly5.1
followedby FITC-avidin (Caltag Laboratories) as the second stage .
For the analysis of allogeneic Thy/Liv constructs, the HLA types
ofthe thymocytes andthe cells recoveredfrom methylcellulose cul-
ture were determined with mAbs against allotypes ofMHC class
I antigens. Cells were resuspended in HBSS-FCS containing 1 tag/ml
propidium iodide and analyzed with gates set to exclude debris,
clumps, and dead cells .
Results
Coimplantation ofHuman Fetal Liverand Thymus Results in
Active Human Hematopoiesis. SCID-humice were constructed
by implanting small fragments ofhuman fetal thymus and/or
fetal liverbeneath the kidney capsule. When thymus implants
were engrafted alone (designated Thy/-), most (>90%) were
observed to initially grow and then recede. Within 3 mo,
the grafts were small and firm by gross examination . Cor-
tical thymocytes were depleted at that time (Fig . 1 A) and
human T cells were no longer detectable in the peripheral
blood. In a minority of cases (<10%), Thy/- grafts were
maintained as long as 11 mo . In these animals, cortical andmedullary thymocytes remained intact and human T cells con-
tinued to mature into the peripheral circulation (see Table 1) .
Continuous human T lymphopoiesis occurredmuch more
frequently when intact fragments of fetal thymus and liver
were coimplanted into the same SCID-hu mice (designated
Thy/Liv) . In 50% of animals, human T cells were detectable
in the peripheral circulation at 6 mo (and in some cases, for
periods of time as long as 15 mo) . On gross examination,
the grafts in these animals were large and soft . Microscopi-
cally, the histology showed a thymus structure which was
indistinguishable from that of a normal human thymus (Fig .
1 B) . Active T lymphopoiesis was reflected in cortical and
medullary areas that were filled with thymocytes . In contrast
to the depletion of cortical double-positive cells observed in
mostThy/- grafts, FACS analysis ofThy/Liv grafts showed
CD4/CD8 profiles containing double-positive thymocytes
comparable to the levels found in normal fetal thymus (Table
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Figure 1 .
￿
Histological features of the
grafts . (A) Typical histology ofThy/-
grafts without hematopoietic activity,
3 mo after implantation . The cortical
area is mainly composed of epithelial
cells (upper hay) ; small number oflym-
phocytes are observed in the medulla
(louvrhay) (Giemsa staining, x 80) . (B)
Typical histology of Thy/Liv grafts
with hematopoietic activity, 6 mo after
implantation. Both cortical (upper hay)
and medullary (burr hay) areas are filled
with thymocytes and the structure of
the thymus is indistinguishable from
that of a normal thymus (Giemsa
staining, x80) . (C) The structure of
the thymic isle. Blast cells, mature and
immature forms of myelomonocytic
cells, andmegakaryocytes are observed
(Giemsa staining, x320) . (D) Im-
munoalkaline phosphatase staining of
thymic isle with Leu-Ml . Most of the
cells are positive for myelomonocytic
lineage marker, Leu-Ml . (x200) .
1) . Hepatocytes were not observed in the Thy/Liv grafts, al-
though structures similar to biliary ducts were sometimes
observed in the periphery of the grafts . Much more frequently,
areas containing hematopoietic blast cells, immature and ma-
ture forms ofmyelomonocytic cells, and megakaryocytes were
observed (Fig . 1 C). Most of the cells found in these areas
(designated thymic isles) were positive for the human my-
elomonocytic marker, Leu-M1 (CD15) (Fig. 1 D) . Some, in-
cluding multi-nucleated large cells (as shown in Fig. 1 C),
were also stained with a mouse mAb against the platelet related
antigen, gpIIb (CD41) (AMAC, Inc ., Westbrook, ME) .
Thymic isles localized in the septal area of the thymic im-
plant, particularly in areas in which the septum invaginated
the thymic medulla (Fig . 4 D) . Microscopically, these areas
had a structure similar to that of normalhuman bone marrow.
Thymic isles were also observed in the rare Thy/- grafts that
sustained hematopoiesis for long periods of time .These findings suggested that Thy/Liv grafts were associated
with multilineage human progenitor cell activity. To dem-
onstrate this activity directly, cells from the grafts were pre-
enriched for TN cells by negative selection forT cell markers
(CD3, CD4, CD8), and then plated in the methylcellulose
colony assay. The results, summarized in Table 1, showed
that 8 of 10 grafts (80%) contained progenitor cell activity
for CFU-c . Colonies of both the CFU-GM lineage and the
BFU-E lineage were observed in most cases ofthe grafts, 6-11
mo after transplantation . The cells recovered from CFU-GM
andBFU-E colonies were pooled and stained with either the
human-specific antibody, MEM-43, or the mouse-specific an-
tibody, Ly5.1, to confirm that they originated from human
progenitors (Fig . 2) . The vast majority of these cells (>70%)
were positive for MEM-43 in all the samples analyzed (n =
20) ; none of them had a significant number of mouse cells
stained with Ly5.1 . Even when most of the pooled colonies
were BFU-E, most of the cells were still positive for MEM-
43 . These results strongly suggested that the cells derived
fromCFU-GM and those from BFU-E were ofhuman origin .
HumanHematopoietic Progenitor Cells in the Thy/Liv Grafts
AreDerivedfrom the Fetal Liver . Coimplantation ofsyngeneic
fetal liver and thymus resulted in reproducible and long-term
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human hematopoiesis, whereas implantation of thymus alone
usually did not . To test the possibility that hematopoietic
progenitor cells and/or stromal cells from the fetal liver were
responsible for this activity, SCID-hu mice were prepared
with combinations ofhuman fetal liver and thymus that were
allogeneic with respect to humanMHC class I antigens.mAbs
against marker class I antigens were then used to trace cell
movement .
In 23 of the 41 allogeneic Thy/Liv grafts analyzed (56%),
long-termT lymphopoiesis (5-11 mo) was documented both
by the presence of mature human T cells in the peripheral
circulation and by the maintenance of a cortical component
of immature CD4+ /CD8 + thymocytes . In addition, hema-
topoietic progenitor cells could be detected with a frequency
(16 of 19, or 84%) similar to that ofsyngeneic Thy/Liv grafts
(80%) . Some of those results are summarized in Table 2 . The
HLA types of medullary thymocytes and the cells recovered
from CFU-c assay were analyzed. Invariably, it was found
that progenitor activity in the Thy/Liv implants was derived
from the fetal liver. A representative experiment is shown
in Fig . 3 . In this case, the thymus donor was HLAA3+,
A2 - , B7- (stained with GAPA3); the fetal liver donor was
HLA-A3+, A2+, 137 - (stained with GAPA3 and MA2.1) .
' Phenotype of thymocytes, 4+/8+ ; CD4 and CD8 double-positive, 4+/8- ; CD4 single-positive, 4- /8+ ; CD8 single-positive, 4 - /8 - ; CD4 and
CD8 double-negative .
$ CD3 -,CD4-,CD8- triple negative population .
5 Standard deviation .
II Calculated per 106 whole thymocytes .
Table 1 . CD4/CD8 Profile and Progenitor Cell Activity in Fetal Thymus,
Thymocytes'
Thy/-, and Thy/Liv Syngeneic Grafts
CFU-c(/105 TNT)
Construct Incubation 4 +/8+ 4+ /8 - 4-/8+ 4- /8- CFU-GM BFU-E
Ungrafted (19 gw) 85.9 6.9 3.0 4.1 20.5 15.0
thymus (22 gw) 72.9 17.4 4.0 5.6 16.9 10.0
Thy/- 9-11 wk 2.5 32.2 49.7 15.9 ND ND
(10 cases) ±6.1S ±13.8 ±15.1 ±10.9 ND ND
Thy/- 11 mo 70 .1 24.6 3.9 1.4 1.3 8.7
11 mo 61 .1 31.8 5.5 1.7 0.0 0 .7
Thy/Liv 11 mo 71.9 20.4 6.7 1.0 6.5 6.9
11 mo 70.4 21.9 7.0 0.8 12.0 15 .0
11 mo 60.2 29.2 9.2 1.5 0.0 0.0
7 mo 78.1 17.0 3.7 1.2 3.0 36 .8
7 mo 77 .5 17 .4 4.3 0.8 17.0 50.8
7 mo 74 .0 19.7 4.5 1.9 5.6 11 3,211
6 mo 73 .1 20.5 5 .2 1 .2 4.0 22 .7
6 mo 72.2 22.2 4.5 1 .1 44.6 60.8
6 mo 49 .5 33 .5 15 .1 1 .9 2.6 6 .9
6 mo 7.0 20.0 8.8 64.2 0.0 0.0Figure 2 .
￿
Immunofluorescence analysis ofthe cells recovered from CFU-c
assay. The cells recovered from the methylcellulose culture were stained
with either human-specific antibody, MEM-43 (A), or mouse-specific an-
tibody, Ly5 .1 (B) . Cells stained with FITC-avidin as a control showed
minimum reactivity (0.16%) . Most ofthe cells were positive forMEM-43
(76%), whereas a small population of the cells were positive for Ly5 .1
(3.8%) .
6 mo after coimplantation of these organs, FACS analysis of
medullary thymocytes demonstrated high level staining with
the anti-HLA class I framework antibody, W6/32, and the
antibody specific for the fetal liver donor, MÁ2.1 (Fig. 3 A) .
When CD3- , CD4 - , CD8 - thymocytes were plated in
methylcellulose, CFU-GM, andBFU-E formed . These cells,
too, were stained with MÁ2 .1 and positive forHLA-A2 (Fig .
3 B) .
The allogeneic coimplants of fetal liver and thymus were
examined by immunohistology. In a representative example
shown in Fig . 4, the thymus donor wasHLAB7+ (stained
withBB7.1 and MB40.2) and the fetal liver donor wasHLA
A2+ (stained with MA2.1 and BB7.2) . 7 mo after coimplan-
tation, biopsy sections were stained with either antibody. Ep-
ithelial cells in the cortex and medulla were still HLA-B7
(Fig. 4A) . Most of the other cells in the graft were derived,
however, from the HLA-A2+ fetal liver donor. These in-
cluded medullary thymocytes, macrophages in the cortex (Fig .
4 B), as well as the diverse populations of cells found within
the thymic isles (Fig . 4, C and D) .
The results of theHLA typing ofthymocytes, macrophages
in thymus, and cells recovered from CFU-c assay are summa-
rized in Table 2. Cortical macrophages and medullary thymo-
cytes showed the HLA type of the fetal liver donor in all
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Figure 3 .
￿
Analysis of HLA type of thymocytes (A) and CFU-c (B)
originating from allogeneic Thy/Liv graft, 6 mo after implantation . The
thymus donor was positive forGAPA3 and the liver donor for both GAPA3
and MÁ2 .1 . Antibody BB7 .1, which was irrelevant to both donors, was
included as a control . (A) The thymocyte suspension was stained with
the cocktail of PE-OKT3, -OKT4, and -OKT8 and FITCW6/32, -MÁ2 .1,
or -BB7 .1 . Those that express MHC class I antigens (defined by W6/32)
were positive for theHLA type ofthe fetal liver donor (MÁ2.1) . (B) Cells
recovered from methylcellulose culture were stained with FITCW6/32,
-MÁ2 .1 or -BB7 .1 . Cells positive for W6/32 and the fetal liver donor
type (MÁ2 .1) were observed.
cases analyzed by immunohistology. Although medullary
thymocytes were observed by FRCS analysis to have a chi-
meric status in some cases, the major population was shown
by HLA typing to originate from the fetal liver donor. Mixed
cell populations comprised of CFU-GM and BFU-E were
also demonstrated to originate from fetal liver donor. How-
ever, these were likely to represent the HLA types expressed
on granulocyte/macrophage lineage cells because not all of
the cells from BFU-E may express HLA molecules . Thus,
in association with the microenvironment of the fetal thymus,
progenitor cell(s) carried within the fetal liver fragments were
able to give rise to long-term T cell maturation as well as
to differentiation along the myelomonocytic and possibly
erythroid pathways .
Absence of Graft-versus-Host Disease in SCID-hu Mice after
Long-Term Hematopoietic Reconstitution . The SCID-hu mice
described in this report had mature human T cells in the pe-
ripheral circulation for long periods of time . In other experi-
ments, these cells have been shown to be functional, responding
in vitro to mitogens as well as to antibodies against CD3
(Krowka, J.F., et al ., manuscript in preparation) . To evaluate
whether these cells were reacting against the host mouse
tissues, organs such as liver, skin, gut, spleen, and lung from
a total of 10 SCID-hu mice were examined 5-11 mo after
Thy/Liv implantation . Macroscopically and microscopically,
no pathological changes of graft-versus-host disease (GVHD)
were observed .Discussion
In this report, we describe an improved construction of
the SCID-hu mouse. Whenhuman fetal liver was transplanted
into the SCID mouse as an intact organ along with human
fetal thymus, human hematopoiesis was established reproduc-
ibly, along multiple lineages, and for long periods of time .
The two organs joined as unique Thy/Liv structures, which
often developed focal areas ofhematopoietic activity. Micro-
scopically, these areas (thymic isles) were similar to normal
human bone marrow, containing blast cells, immature and
mature forms of granulocytes, and megakaryocytes. When
plated in the methylcellulose colony assay to test for hemato-
poietic progenitor cell activity, the Thy/Liv grafts yielded
CFU-c for the myelomonocytic and erythroid lineages . In
vivo, progenitors to the T lymphoid lineage were evidenced
by the continued production of immature cortical thymo-
cytes and mature human T cells in the thymus and their
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Figure 4 . The expression of the
MHC class I antigens in an allogeneic
Thy/Liv graft, 7 mo after implantation,
as analyzed by immunoalkaline phos-
phatase method. The thymus donor
was positive for HLA-B7 (stained with
BB7 .1 andMB40.2) and the fetal liver
donor was positive forHLAA2 (stained
with MA2 .1 and BB 7.2) . (A) Section
was stained with BB7.1 . Epithelial cells
in both cortical (upper hay) and medul-
lary (lower hay) areas were positive for
thymus donor type, HLA-B7 (x 120) .
(B) Section was stained with MA2 .1 .
Medullary thymocytes (lower hay) and
macrophages with dendritic shape in
the cortical area (upper hay) were posi-
tive for the liver donor type, HLA-A2
(x120) . (C) Section was stained with
MA2 .1. Cells in the thymic isle (center)
as well as medullary thymocytes (lower
left) were positive for the liver donor
type, HLA-A2 (x160) . (D) Histology
of the thymic isle shown in C . The
cluster of myelomonocytic cells is lo-
cated in the septal area adjacent to the
medullary area of the thymus (Giemsa
staining,
￿
x160) .
progeny in the peripheral blood . All of these progenitor ac-
tivities were maintained in the Thy/Liv grafts for periods
of time ranging between 5 and 11 mo. Finally, all were de-
rived from hematopoietic cells donated by the fetal liver, and
not the fetal thymus, implant . These findings indicate that
SCID-hu mice with human Thy/Liv coimplants contain
stromal microenvironment(s) requisite for the long-term main-
tenance ofhuman hematopoietic progenitor cells. As such,
this animal model permits systematic evaluation of human
hematopoiesis.
In previous studies with SCID-hu mice, long-term human
hematopoiesis did not occur (14) . Immature cortical thymo-
cytes of the human thymic graft eventually became depleted ;
mature human T cells in the peripheral blood disappeared
after 2-3 mo. These cells may have been destroyed, sequestered
elsewhere, and/or simply not replenished. Given the design" See same footnote of Table 1 legend .
t See same footnote of Table 1 legend .
S HLA type of macrophages in thymus analyzed by immunohistology .
II HLA type of medullary thymocytes analyzed by immunohistology/FACS .
1 HLA type of cells derived from CFU-GM and BFU-E analyzed by FACS .
" See footnote II of Table 1 legend .
# HLA type of fetal liver donor.
of the experiment, the latter possibility seemed probable. The
hematopoietic cell fraction ofhuman fetal liver (containing
progenitor cell activity) had been teased away from the stromal
matrix of the organ . Once injected intravenously into SCID-hu
mice with human thymic implants, long-term hematopoi-
esis did not ensue. Likely, hematopoietic progenitor cells had
been provided in limiting numbers and/or without the neces-
sary conditions for self-renewal .
In the current study, the fetal liver was instead implanted
intact . Hematopoietic progenitor cells were introduced to-
gether with the hepatic stromal cells with which they nor-
mally interact . Technically and conceptually, this process is
simple. With fewer manipulations, more ofthe elements neces-
sary for active human hematopoiesis (most ofwhich are un-
known) may be implanted as a fully functional unit . The
liver grafts do not grow on their own when placed beneath
the kidney capsule of the SCID mouse. When, however, the
fetal liver is coimplanted with grafts of human thymus, a
novel structure (Thy/Liv) is formed. Inmany cases, this struc-
ture is associated with multilineage human progenitor cell
activity when assayed in vitro. Functional hematopoiesis is
then maintained in vivo for periods of time as long as 15 mo.
Multiple dynamics may underlie the genesis ofthe Thy/Liv
structure . It is possible to envision a chimeric association be-
tween some cell populations of the fetal liver and those of
the thymus . Fetal liver cells that move into the parenchyma
of the thymus could thereafter be maintained. Coimplanta-
tion of fetal liver adjacent to thymus may also have an in-
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direct effect, e.g., by way of diffusible factors. In all proba-
bility, these and other influences occur simultaneously. The
hematopoietic cell fractions of the fetal liver donor, for in-
stance, move into and/or through the thymus. Demonstrated
in a transient assay before, this differentiation process is shown
here to occur in a fashion which is both stable and reproduc-
ible. Over 50% of the Thy/Liv implants sustain human he-
matopoiesis . All of those analyzed in an allogeneic setting
demonstrate repopulation by the hematopoietic cells from
the fetal liver donor. It is not clear that the stromal cells of
the thymic isles are also derived from the fetal liver donor.
These cells may instead be thymic-derived and with diverse
biologic potential . In the current studies, someSCID-hu mice
with thymic implants alone showed the same, suggesting that
the thymus itself has the microenvironment(s) that can sup-
port progenitor cells . Others have reported progenitor cell
activity in fetal and neonatal thymus (19 ; Weilbaecher, K.N.,
unpublished observations) and the activity of thymic epithe-
lial cells to induce myelomonocytic differentiation of progenitor
cells (19) .
Irrespective of the pathways by which the Thy/Liv im-
plants are formed, the data suggest that they are suitable
microenvironments for the long-term maintenance ofhuman
hematopoietic progenitor cells. Using a combination of in
vitro and in vivo assays, maturation of these cells into the
T lymphoid, erythroid, myelomonocytic, and megakaryocytic
series was observed . It is not clear whether there is one long-
lived population of pluripotent (stem) cells and/or multiple
Table 2 . CD4/CDS Profile, Progenitor Cell Activity, andHLA Type of Various Lineages of Cells in Allogeneic Thy/Liv Craft
Thymocytes" CFU-c(/105 TM) HLA
Incubation 4+/8+ 4+/8- 4 -/8+ 4- /8 - CFU-GM BFU-E Mos TII CFU-ct
8 mo 72 .0 23.4 3.6 1.0 0.0 0.0 Lt# L/L ND
7 mo 86 .7 10.4 2 .2 0.8 85.9 0.0 L L/ND L
7 mo 57.6 30.4 9 .3 2.7 0.0 0.0 L L/ND ND
6 mo 79.9 14.9 4 .5 0.7 0.0" 1 .3"" L L/L ND
6 mo 79.8 14.9 3 .7 1.5 19.3 38 .5 L L/L L
6 mo 73 .7 18.9 5 .7 1.7 8.1 48 .4 L L/L L
5 mo 85 .0 8.8 5 .6 0.6 4.8'" 4.8"" L L/L ND
5 mo 82.8 11.4 5 .3 0.5 6 .5 3 .5 L L/L L
5 mo 79.7 13.2 6.6 0.5 3.7 2.4 L L/L L
5 mo 76.2 14.1 8 .9 0.8 0.8"' 0.0"" L L/L ND
5 mo 67.2 24.4 7.4 1.1 0 .0 1 .0 ND L/L ND
5 mo 65 .2 25.0 8 .7 1.1 3.5 4.0 ND L/L Lpopulations of long-lived, lineage-restricted progenitors . It
is now possible, however, to discriminate among these alter-
natives and to identify diverse subpopulations of cells by trans-
ferring them specifically into SCID-hu mice with Thy/Liv
implants . Taking advantage of the unique microenvironment
of these implants, the mouse could thus provide an in vivo
read-out for human hematopoietic progenitor cells .
The improvements reported here in the SCID-hu mouse
are still not complete. First, biologic variability remains be-
tween donor tissues, individual animals, and cohorts of
animals . Even gross functions, such as the presence or ab-
sence of sustained hematopoiesis, are only observed in 50%
of the animals . Even among these animals, there is a range
in the level ofreconstitution by donor fetal liver hematopoi-
etic cells. Such biologic diversity is a reality in any complex
system . Experimental designs must therefore be either inde-
pendent of these variables or observant of their effect of the
data. On a more general level, the hematopoietic function
of the Thy/Liv transplants is in some obvious ways different
than that which occurs physiologically inman . Even though
human progenitor cells to multiple lineages can be maintained,
not all ofthem differentiate with equal efficiency in vivo . When
analyzed by FACS, human T cells are found in the periphery
but no cells in other lineages, such as B cells, granulocytes,
and macrophages are observed . Myelomonocytic cells and
megakaryocytes are confined instead within the Thy/Liv pa-
renchyma . Further, even those cell populations that do differen-
tiate well in the SCID-hu (e.g., T cells) do not exist later
in abundance. If these are points of limitation, they also serve
as a foundation for further improvement . In a quantitative
or qualitative sense, specific growth factors and/or cell popu-
lations may still be deficient . Once provided in appropriate
amounts or anew, hematopoietic functions that are not now
present maybecome apparent . If so, improvement of the SCJD-
hu mouse will be accompanied by additional insight into the
complex regulatory mechanisms surrounding hematopoiesis
per se .
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grafts. In essence, this system provides the first small animal
model for long-term human hematopoiesis. After engraft-
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Finally, the continual differentiation of human hemato-
poietic cells along the T lymphoid lineage provides a solid
basis for studies on human immune function . As shown in
this report, current data are most striking in the description
of functions not present, to wit, the absence of GVHD. It
is to be expected that mature human peripheral blood cells
might initiate a xenograft reaction when injected into SCID
mice, and indeed, histologic evidence ofGVHD has been ob-
served bysome (23, 24) but not all (25) groups making "hu-
PBIrSCID" mice. In contrast, similar histologic examination
ofSCID-hu mice shows no signs ofGVHD, even in animals
that have had circulatinghumanT cells for 5-11mo . Experi-
ments are currently in progress to determine if this is due
to a lack of function, or alternatively, to the acquisition of
tolerance during the course ofdifferentiation. These and other
studies should contribute to our understanding of means by
which to actively turn on or off specific human immune re-
sponses in the SCID-hu mouse.
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